Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty

Journal of Bone and Joint Surgery

Volumn 96, Issue 4, 2014, Pages 272-278

  Friedman, Richard ^a   Homering, Martin ^b   Holberg, Gerlind ^b   Berkowitz, Scott D ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BAYER PHARMA AG   (Germany)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BONE INFECTION; CONTROLLED STUDY; HIP ARTHROPLASTY; HUMAN; INFECTION RISK; INFECTIOUS ARTHRITIS; INFLAMMATION; LUNG INFECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84896291988     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.01268     Document Type: Article

References (36)

1. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008 Jun 26;358 (26):2765-75.
2. Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008 Jul 5;372 (9632):31-9. Epub 2008 Jun 24.
3. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AGG; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008 Jun 26;358 (26):2776-86.
4. Turpie AGG, LassenMR, Davidson BL, Bauer KA, GentM, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 May 16;373 (9676): 1673-80. Epub 2009 May 4.
5. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003 May;85 (4):484-9.
6. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2010 Jul;468 (7):1905-11. Epub 2010 Jan 9.
7. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012 Sep;470 (9):2605-12. Epub 2012 Mar 15.
8. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010:CD001888.
9. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus Med. 1996 Dec;6 (4):325-8.
10. ParkMS, Moon SH, Kim HS, Hahn SB, Park HW, Park SY, Lee HM. A comparison of autologous and homologous transfusions in spinal fusion. Yonsei Med J. 2006 Dec 31;47 (6):840-6.
11. Selo-Ojeme DO, Feyi-Waboso PA. Salvage autotransfusion versus homologous blood transfusion for ruptured ectopic pregnancy. Int J Gynaecol Obstet. 2007 Feb;96 (2):108-11. Epub 2007 Jan 19.
12. Basora M, Pereira A, Soriano A, Martínez-Pastor JC, Sánchez-Etayo G, Tío M, Salazar F. Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Vox Sang. 2010 Feb;98 (2):124-9. Epub 2009 Sep 14.
13. Wong JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN; ATIS Investigators. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg. 2002 Jan;235 (1):145-51.
14. Vamvakas EC, Moore SB, Cabanela M. Blood transfusion and septic complications after hip replacement surgery. Transfusion. 1995 Feb;35 (2):150-6.
15. Parrot D, Lancxon JP, Merle JP, Rerolle A, Bernard A, Obadia JF, Caillard B. Blood salvage in cardiac surgery. J Cardiothorac Vasc Anesth. 1991 Oct;5 (5):454-6.
16. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion. 2005 Jan;45 (1):103-10.
17. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL, OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003 Apr;43 (4):459-69.
18. Mercer KG, Spark JI, Berridge DC, Kent PJ, Scott DJ. Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. Br J Surg. 2004 Nov;91 (11):1443-8.
19. Steinitz D, Harvey EJ, Leighton RK, Petrie DP. Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg. 2001 Oct;44 (5): 355-8.
20. Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. Br J Anaesth. 2001 May;86 (5):669-73.
21. Shenolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M. Cell salvage auto transfusion in total knee replacement surgery. Transfus Med. 1997 Dec;7 (4):277-80.
22. Spark JI, Chetter IC, Kester RC, Scott DJ. Allogeneic versus autologous blood during abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 1997 Dec; 14 (6):482-6.
23. Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs. 1997 Dec;15 (4): 111-5.
24. Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A, Jemos V, Di Carlo V. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg. 1995 Jul;161 (7):487-92.
25. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993 Nov 27;342 (8883): 1328-33.
26. Murphy PJ, Connery C, Hicks GL Jr, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg. 1992 Oct;104 (4):1092-9.
27. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006; (4):CD001888. Epub 2006 Oct 18.
28. Turpie AGG, Lassen MR, Eriksson BI, Gent M, Berkowitz SD, Misselwitz F, Bandel TJ, HomeringM, Westermeier T, Kakkar AK. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. Thromb Haemost. 2011 Mar;105 (3):444-53. Epub 2010 Dec 6.
29. Medical Dictionary for Regulatory Activities, Maintenance and Support Services Organization. About MedDRA. 2012. http://www.meddra.org. Accessed 2013 Apr 19.
30. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion. 1992 Jul-Aug;32 (6):517-24.
31. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol. 1994 Nov;1 (6):457-61.
32. Depcik-Smith ND, Hay SN, Brecher ME. Bacterial contamination of blood products: factors, options, and insights. J Clin Apher. 2001;16 (4):192-201.
33. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation. 2004 Jun 8;109 (22): 2755-60. Epub 2004 May 17.
34. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 1998 Nov;176 (5):462-6.
35. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996 Sep 28;348 (9031):841-5.
36. Jensen CD, Steval A, Partington PF, Reed MR, Muller SD. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br. 2011 Jan;93 (1):91-5.